Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Klaus Metzeler

Professor of Translational Hematology

Leipzig University

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

LinkedIn ORCID

Google Scholar

Academic Page

Research Interests

Immunology

20%

Cell Biology

20%

Hematology

50%

Graft-versus-host Disease

50%

Hematopoiesis

30%

Cancer Biology

30%

Cancer Genetics

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Letter to the Editor: Clonal hematopoiesis in MASLD-associated HCC: Variant burden may matter more than presence

Article Link

Year:

2025

Sex-associated differences in outcome of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation

Article Link

Year:

2025

Impact of Evolving WHO and ICC Classifications on Prognosis and Outcomes in AML Patients Undergoing Allogeneic Stem Cell Transplantation

Article Link

Year:

2025

Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

Article Link

Year:

2024

Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche

Article Link

Year:

2024

Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation

Article Link

Year:

2024

Activation of distinct inflammatory pathways in subgroups of LR-MDS

Article Link

Year:

2023

Lessons learned: the first consecutive 1000 patients of the CCCMunich(LMU) Molecular Tumor Board

Article Link

Year:

2023

WT1 and DNMT3A play essential roles in the growth of certain patient AML cells in mice

Article Link

Year:

2023

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

Article Link

Year:

2023

Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy

Article Link

Year:

2023

Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles

Article Link

Year:

2023

Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease

Article Link

Year:

2023

Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study

Article Link

Year:

2022

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation

Article Link

Year:

2022

Clonal hematopoiesis and cardiovascular disease: deciphering interconnections

Article Link

Year:

2022

Collaborators10

Madlen Jentzsch

GERMANY

Petra Büttner

Head of Lab

Heart Center Leipzig at University of Leipzig

GERMANY

Frederick Klauschen

Professor, Chair

Ludwig-Maximilians-Universität München

GERMANY

Tobias Herold

University Hospital, LMU Munich

GERMANY

Michael Menden

University of Melbourne

AUSTRALIA

Janghee Woo

Winship Cancer Institute

UNITED STATES

Marion Subklewe

LMU University Hospital

GERMANY

Thomas Berg

Head of Division

Heart Center Leipzig at University of Leipzig

GERMANY

Philipp Greif

University Hospital, LMU Munich

GERMANY

Michael Cross

Head of Laboratory Research

Leipzig University

GERMANY

How do I reach out?

Meet Kite AI